Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Valeant Pharmaceuticals Intl Inc (VRX), Bill Ackman on Radars Over Allergan, Inc. (AGN) Insider Trading Scandal

Billionaire investor and hedge fund Manager Bill Ackman of Pershing Square has been in the news recently for all the wrong reasons. Allergan, Inc. (NYSE:AGN) has filed a lawsuit against him accusing him of insider trading. Andrew Ross Sorkin and CNBC’s Squawk Box team discussed Sorkin’s own column in the Monday edition of the New York Times. Sorkin had written that Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s deal with Ackman may be too clever to be legal.

Bill Ackman in crowd

‘‘How is it possible that the CEO of Valeant calls you, you go buy shares, and somehow that’s all legit?’’ asked Sorkin. Joe Kernen was quite voluble in his agreement. “It is legal technically. However, my point is that it stinks,” he noted. Becky Quick pointed out that in his defense, Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) had a whole array of lawyers looking into the legitimacy of the transaction. Robert S. Khuzami, former head of enforcement at the SEC, is one of the most notable among them.

Sorkin stated that the SEC may have to change the rules in light of the recent developments in the Valeant Pharmaceuticals Intl Inc (NYSE:VRX) – Allergan, Inc. (NYSE:AGN) case. Quick seemed to be in agreement and felt that this might set a bad trend with others following suit. This might be easier said than done as it was unclear if the SEC had the authority to change the law and they ‘might need a Congressman to enact the law to make this work’, said Sorkin.

The lawsuit in question was filed by Botox manufacturer Allergan, Inc. (NYSE:AGN) claiming that Bill Ackman was allegedly in cahoots with another pharmaceutical major Valeant Pharmaceuticals Intl Inc (NYSE:VRX) involving a hostile takeover plan of the former. It is also important to point out the fact that Ackman’s Pershing Square is Allergan’s largest investor.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!